首页> 外文期刊>International Journal of Pharmacy and Pharmaceutical Sciences >DECIPHERING THE ACTION MECHANISM OF INDONESIA HERBAL DECOCTION IN THE TREATMENT OF TYPE II DIABETES USING A NETWORK PHARMACOLOGY APPROACH
【24h】

DECIPHERING THE ACTION MECHANISM OF INDONESIA HERBAL DECOCTION IN THE TREATMENT OF TYPE II DIABETES USING A NETWORK PHARMACOLOGY APPROACH

机译:网络药理学方法研究印尼药草汤治疗Ⅱ型糖尿病的作用机制

获取原文
           

摘要

Objective: The aim of this research was to investigate action mechanism of Indonesia herbal decoctions in the treatment of Type 2 Diabetes (T2D) using network pharmacology approaches. Methods: Drug target profile analysis via Markov clustering was performed to identify the potent antidiabetic ingredients in the four herbs. Network target base identification of multicomponent synergy was applied to predict the ingredients synergetic effect. The multi-level and integrated target networks were contracted to identify the herbs major ingredients and their presumed targets. Further enrichment analysis and molecular docking were performed to validate network targets. Results: 278 ingredients from the four herbs were linked to antidiabetic drugs with an overall clustering success rate of 98.58% and 5 ingredient pairs had significant synergetic effects. Enrichment analysis demonstrates herbs candidate presumed targets were frequently involved in the significant biological process and pathways associated with progression of Type 2 diabetes (T2D) diseases. Finally, molecular docking validation revealed there was high binding site similarity between momordicoside F2 (78%), beta-sitosterol (67%) and cis-N-Feruloyltyramine (67%) with miglitol drug. In addition, the four ligands presented the higher binding affinity to Maltase-glucoamylase (MGA) receptor an enzyme responsible for the digestion of dietary starch to glucose. Conclusion: This study revealed the pharmacological mechanism of action of Indonesia herbal decoctions in the treatment of Type 2 diabetes. The herbs major presumed target played a significant biological role in the progression of Type 2 diabetes (T2D) while major herbal ingredients indicates the potential of curing Type 2 diabetes by inhibiting Maltase-glucoamylase (MGA) activity.
机译:目的:本研究的目的是通过网络药理学方法研究印尼草药汤治疗2型糖尿病(T2D)的作用机制。方法:通过马尔可夫聚类进行药物靶标谱分析,以鉴定四种草药中有效的抗糖尿病成分。采用多目标协同作用的网络目标库识别方法预测各成分的协同作用。签订了多层次和综合目标网络,以确定草药的主要成分及其假定目标。进行了进一步的富集分析和分子对接,以验证网络目标。结果:四种草药中的278种成分与抗糖尿病药物相关联,总体成簇成功率为98.58%,并且5种成分对具有明显的协同作用。富集分析表明,草药候选推定目标经常参与与2型糖尿病(T2D)疾病进展相关的重要生物学过程和途径。最终,分子对接验证显示,莫高糖苷F2(78%),β-谷甾醇(67%)和顺式-N-Feruloyltyramine(67%)与米格列醇药物之间具有很高的结合位点相似性。另外,这四个配体对马耳他糖-葡糖淀粉酶(MGA)受体的结合亲和力更高,后者是负责将膳食淀粉消化为葡萄糖的酶。结论:该研究揭示了印尼草药汤治疗2型糖尿病的药理作用机理。草药的主要推定目标在2型糖尿病(T2D)的发展中起着重要的生物学作用,而主要的草药成分则表明可以通过抑制Maltase-葡糖淀粉酶(MGA)活性来治愈2型糖尿病。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号